Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: A case review analysis from a single center

QJM: An International Journal of Medicine

Volumn 105, Issue 6, 2012, Pages 545-550

  Besada, E ^a   Koldingsnes, W ^a   Nossent, J ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CLINICAL ARTICLE; COLITIS; CONCURRENT INFECTION; CRYOGLOBULINEMIA; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; GRANULOCYTE; GRANULOMATOSIS; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY TRANSPLANTATION; LATE ONSET NEUTROPENIA; LEUKOCYTOCLASTIC VASCULITIS; LEUKOPENIA; MALE; MEDICAL RECORD REVIEW; MICROSCOPIC POLYANGIITIS; MYELOMA; NEUTROPENIA; NEUTROPHIL COUNT; PANCYTOPENIA; PRIORITY JOURNAL;

EID: 84861740428     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs015     Document Type: Article

References (11)

1. Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis, 15: 2011; e2-16.
2. Wolach O, Bairey O, Lahaw M. Late-onset neutropenia after rituximab treatment. Case series and comprehensive review of the literature. Medicine, 89: 2010, 308-18.
3. Rios-Fernandez R, Gutierrez-Salmeron MT, Callejas-Rubio JL, Fernandez-Pugnaire M, Ortego-Centeno N. Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases. Br J Dermatol, 157: 2007, 1271-3.
4. Tesfa D, Ajeganova S, Hägglund H, Sander B, Fadeel B, Hafström I, et al. Late-onset neutropenia following rituximab in rheumatic diseases: association with B lymphocytes depletion and infections. Arthritis Rheum, 63: 2011, 2209-14.
5. Dunleavy K, Tay K, Wilson WH. Rituximab-associated neutropenia. Semin Hematol, 47: 2010, 180-6.
6. Grant C, Wilson WH, Dunleavy K. Neutropenia associated with rituximab therapy. Curr Opin Hematol, 18: 2010, 49-54.
7. Cooper N, Arnold DM. The effect of Rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol, 149: 2010, 3-13.
8. Hincks I, Woodcock BE, Thachil J. Is Rituximab -induced late-onset neutropenia a good prognostic indicator in lymphoproliferative disorders? Br J Haematol, 153: 2011, 411-3.
9. Samson M, Audia S, Lakomy D, Bonnotte B, Tavernier C, Ornetti P. Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology. Joint Bone Spine, 78: 2011, 241-5.
10. Diwakar L, Gorrie S, Richter A, Chapman O, Dhillon P, Al-Ghanmi F, et al. Does Rituximab aggravate preexisting hypogammaglobulinaemia? J Clin Pathol, 63: 2010, 275-7.
11. Furst DE. Serum immunoglobulins and risk of infection: How low can you go? Semin Arthritis Rheum, 39: 2008, 18-29.